v3.26.1
Pay vs Performance Disclosure
number in Thousands
 12 Months Ended
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Pay vs Performance Disclosure          
Pay vs Performance Disclosure, Table
Year
Summary Compensation Table Total for Principal Executive Officer (“PEO”)(1)
Compensation Actually Paid to PEO(3)
Average Summary Compensation Table for Non-PEO NEOs(1)(2)
Average Compensation Actually Paid to Non-PEO NEOs(3)
Value of Initial Fixed $100 Investment Based On:Net Income
('000s)
Adjusted EBITDA
('000s)(5)
Total Shareholder Return(4)
Peer Group Total Shareholder Return(4)
20256,452,042 $9,200,048 $3,196,655 $4,316,970 $66.52 $67.95 $732 $403,835 
20246,454,754 $23,086,469 $3,250,189 $9,873,884 $82.93 $96.08 $(117,688)$370,497 
2023$6,810,975 $(8,069,662)$3,368,051 $161,322 $53.30 $105.67 $(29,655)$376,115 
2022$5,657,069 $(11,280,427)$2,790,873 $978,391 $84.16 $99.88 $(74,286)$358,653 
2021$5,071,358 $13,341,251 $2,648,345 $3,791,063 $126.84 $152.33 $103,135 $260,699 
        
Company Selected Measure Name Adjusted EBITDA        
Named Executive Officers, Footnote Amounts reported in this column represent (i) the total compensation reported in the Summary Compensation Table for the applicable year for the Company's PEO, Vivek Jain and (ii) the average of the total compensation reported in the Summary Compensation Table for the applicable year for the Company’s non-PEO named executive officers (NEOs).(2) The Company's non-PEO NEOs for the applicable years 2025, 2024, 2023, 2022 and 2021 were Brian Bonnell, Christian Voigtlander, Daniel Woolson and Virginia Sanzone.        
Peer Group Issuers, Footnote Assumes $100 invested on December 31, 2020 in ICU Medical Inc.'s common stock and the NASDAQ Medical Supplies Index and that all dividends, if any, were reinvested. As permitted by SEC Rules, the peer group referenced for purpose of the TSR Comparison is the industry peer group used for purposes in Item 201(e) of Regulation S-K. The separate peer group used by the Compensation Committee for purposes of determining compensation paid to our executive officers is described on page 17.        
PEO Total Compensation Amount $ 6,452,042 $ 6,454,754 $ 6,810,975 $ 5,657,069 $ 5,071,358
PEO Actually Paid Compensation Amount $ 9,200,048 23,086,469 (8,069,662) (11,280,427) 13,341,251
Adjustment To PEO Compensation, Footnote Amounts reported in the applicable column represent (i) the compensation actually paid to the PEO and (ii) the average compensation actually paid to the non-PEO NEOs. The fair values as of each measurement date were determined using valuation assumptions and methodologies that are generally consistent with those used to estimate fair value at grant in accordance with ASC Topic 718. For time-based RSUs the valuation assumptions used to determine the change in the fair market value of the respective PEO and non-PEO NEO equity awards for each respective year use the stock price as of year-end or as of the applicable exercise/vesting date. For PRSUs, the valuation assumptions used to determine the change in the fair market value of the respective PEO and non-PEO NEO equity awards for each respective year reflect the probable outcome of the performance vesting conditions as of each measurement date. See the tables below for additional information with respect to the equity award adjustments.
2025
Summary Compensation Table - Total Compensation(a)$6,452,042 
-Grant Date Fair Value of Stock Awards and Option Awards Granted in Fiscal Year as Reported in the Summary Compensation Table for 2025.(b)$(4,500,023)
+Fair Value at 2025 Fiscal Year End of Outstanding and Unvested Stock Awards and Option Awards Granted in 2025(c)$7,913,976 
+Change in Fair Value of Outstanding and Unvested Stock Awards and Option Awards Granted in Prior Fiscal Years That Remain Outstanding At 2025 Fiscal Year End(d)$(566,474)
+Fair Value at Vesting of Stock Awards and Option Awards Granted in Fiscal Year That Vested During 2025(e)$— 
+Change in Fair Value as of Vesting Date of Stock Awards and Option Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During 2025(f)$(99,473)
-Fair Value as of 2024 Fiscal Year End of Stock Awards and Option Awards Granted in Prior Fiscal years That Failed to Meet Applicable Vesting Conditions During 2025(g)$— 
=Compensation Actually Paid$9,200,048 
        
Non-PEO NEO Average Total Compensation Amount $ 3,196,655 3,250,189 3,368,051 2,790,873 2,648,345
Non-PEO NEO Average Compensation Actually Paid Amount $ 4,316,970 9,873,884 161,322 978,391 3,791,063
Adjustment to Non-PEO NEO Compensation Footnote Amounts reported in the applicable column represent (i) the compensation actually paid to the PEO and (ii) the average compensation actually paid to the non-PEO NEOs. The fair values as of each measurement date were determined using valuation assumptions and methodologies that are generally consistent with those used to estimate fair value at grant in accordance with ASC Topic 718. For time-based RSUs the valuation assumptions used to determine the change in the fair market value of the respective PEO and non-PEO NEO equity awards for each respective year use the stock price as of year-end or as of the applicable exercise/vesting date. For PRSUs, the valuation assumptions used to determine the change in the fair market value of the respective PEO and non-PEO NEO equity awards for each respective year reflect the probable outcome of the performance vesting conditions as of each measurement date. See the tables below for additional information with respect to the equity award adjustments.
2025
Summary Compensation Table - Total Compensation(a)$3,196,655 
-Grant Date Fair Value of Stock Awards and Option Awards Granted in 2025 as Reported in the Summary Compensation Table for 2025(b)$(2,337,607)
+Fair Value at 2025 Fiscal Year End of Outstanding and Unvested Stock Awards and Option Awards Granted in 2025(c)$4,110,983 
+Change in Fair Value of Outstanding and Unvested Stock Awards and Option Awards Granted in Prior Fiscal Years That Remain Outstanding At 2025 Fiscal year End(d)$(267,419)
+Fair Value at Vesting of Stock Awards and Option Awards Granted in 2025 That Vested During 2025(e)$— 
+Change in Fair Value as of Vesting Date of Stock Awards and Option Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During 2025(f)$(385,642)
-Fair Value as of 2024 Fiscal Year End of Stock Awards and Option Awards Granted in Prior Fiscal years That Failed to Meet Applicable Vesting Conditions During 2025(g)$— 
=Compensation Actually Paid$4,316,970 
        
Compensation Actually Paid vs. Total Shareholder Return
Relationship Between Pay and Performance_Net Income.jpg
        
Compensation Actually Paid vs. Net Income
Relationship Between Pay and Performance_Net Income.jpg
        
Compensation Actually Paid vs. Company Selected Measure
Relationship Between Pay and Performance_Net Income.jpg
        
Tabular List, Table Adjusted EBITDA
–Adjusted Revenue
–Free Cash Flow
        
Total Shareholder Return Amount $ 66.52 82.93 53.30 84.16 126.84
Peer Group Total Shareholder Return Amount 67.95 96.08 105.67 99.88 152.33
Net Income (Loss) $ 732,000 $ (117,688,000) $ (29,655,000) $ (74,286,000) $ 103,135,000
Company Selected Measure Amount 403,835 370,497 376,115 358,653 260,699
PEO Name Vivek Jain        
Additional 402(v) Disclosure
(a) Represents Total Compensation as reported in the Summary Compensation Table for the indicated 2025.
(b) Represents the aggregate grant date fair value of the stock awards and option awards granted to the PEO during 2025, computed in accordance with FASB ASC 718, as reported in the Summary Compensation Table for the indicated fiscal year.
(c) Represents the aggregate fair value as of the 2025 year-end of the PEO's outstanding and unvested stock awards granted during 2025, computed in accordance with FASB ASC 718.
(d) Represents the aggregate change in fair value during 2025 of the outstanding and unvested stock awards held by the PEO as of the last day of 2025, computed in accordance with FASB ASC 718 and, for awards subject to performance-based vesting conditions, as of 2025 fiscal year end, based on the probable outcome of such performance-based vesting conditions as of the last day of 2025, and for performance-based awards with performance periods ending in 2025, based on actual attainment as of the end of the applicable performance period.
(e) Represents the aggregate fair value at vesting of the stock awards that were granted to the PEO and vested during 2025, computed in accordance with FASB ASC 718.
(f) Represents the aggregate change in fair value, measured from 2024 fiscal year-end to the vesting date, of each stock award and option award held by the PEO that was granted in a prior fiscal year and which vested during 2025, computed in accordance with FASB ASC 718.
(g) Represents the aggregate fair value as of the last day of 2024 of the PEO's stock awards and option awards that were granted in a prior fiscal year and which failed to meet the applicable vesting conditions in 2025, computed in accordance with FASB ASC 718.
(a) Represents the average Total Compensation as reported in the Summary Compensation Table for the 2025.
(b) Represents the average aggregate grant date fair value of the stock awards granted to the non-PEO NEOs during 2025, computed in accordance with FASB ASC 718, as reported in the Summary Compensation Table for 2025.
(c) Represents the average aggregate fair value as of 2025 fiscal year-end of the non-PEO NEO's outstanding and unvested stock awards granted during 2025, computed in accordance with FASB ASC 718.
(d) Represents the average aggregate change in fair value during 2025 of the outstanding and unvested stock awards held by the non-PEO NEOs as of the last day of 2025, computed in accordance with FASB ASC 718 and, for awards subject to performance-based vesting conditions as of 2025 fiscal year end, based on the probable outcome of such performance-based vesting conditions as of the last day of 2025, and for performance-based awards with performance periods ending in 2025, based on actual attainment as of the end of the applicable performance period.
(e) Represents the average aggregate fair value at vesting of the stock awards that were granted to the non-PEO NEOs and vested during 2025, computed in accordance with FASB ASC 718.
(f) Represents the average aggregate change in fair value, measured from 2024 fiscal year-end to the vesting date, of each stock award and option award held by the non-PEO NEOs that was granted in a prior fiscal year and which vested during 2025, computed in accordance with FASB ASC 718.
(g) Represents the average aggregate fair value as of the last day of 2024 of the non-PEO NEOs stock awards and option awards that were granted in a prior fiscal year and which failed to meet the applicable vesting conditions in 2025, computed in accordance with FASB ASC 718.
        
Measure:: 1          
Pay vs Performance Disclosure          
Name –Adjusted EBITDA        
Non-GAAP Measure Description As noted in the CD&A, for 2025, the Compensation Committee determined that Adjusted EBITDA serves as one of the most important financial measurements of the Company's performance and shareholder value creation and, accordingly, was utilized as a component in the 2025 MIP and the LTI Program. Adjusted EBITDA is a non-GAAP measure. Our reconciliation of net income to Adjusted EBITDA is included in Annex A to this proxy statement.        
Measure:: 2          
Pay vs Performance Disclosure          
Name –Adjusted Revenue        
Measure:: 4          
Pay vs Performance Disclosure          
Name –Free Cash Flow        
PEO | Equity Awards Granted During The Year, Reported Value [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ (4,500,023)        
PEO | Equity Awards Granted During The Year, Unvested [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 7,913,976        
PEO | Equity Awards Granted In Prior Years, Unvested [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (566,474)        
PEO | Equity Awards Granted During The Year, Vested [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
PEO | Equity Awards Granted In Prior Years, Vested [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (99,473)        
PEO | Equity Awards That Failed To Meet Vesting Conditions [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
Non-PEO NEO | Equity Awards Granted During The Year, Reported Value [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (2,337,607)        
Non-PEO NEO | Equity Awards Granted During The Year, Unvested [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 4,110,983        
Non-PEO NEO | Equity Awards Granted In Prior Years, Unvested [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (267,419)        
Non-PEO NEO | Equity Awards Granted During The Year, Vested [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
Non-PEO NEO | Equity Awards Granted In Prior Years, Vested [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (385,642)        
Non-PEO NEO | Equity Awards That Failed To Meet Vesting Conditions [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ 0